Amendment No. 7 Contract Award issued by the Biomedical Advanced Research and Development Authority of the United Sates Department of Health and Human Services, dated June 29, 2021
CERTAIN INFORMATION IDENTIFIED BY BRACKETED ASTERISKS ([* * *]) HAS BEEN OMITTED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
PAGE OF PAGES
2. AMENDMENT/MODIFICATION NO.5. PROJECT NO. (If applicable)
6. ISSUED BY
7. ADMINISTERED BY (If other than Item 6)
US DEPT OF HEALTH & HUMAN SERVICESUS DEPT OF HEALTH & HUMAN SERVICES ASST SEC OF PREPAREDNESS & RESPONSEASST SEC OF PREPAREDNESS & RESPONSE ACQ MANAGEMENT, CONTRACTS, & GRANTSACQ MANAGEMENT, CONTRACTS, & GRANTS O'NEILL HOUSE OFFICE BUILDINGO'NEILL HOUSE OFFICE BUILDING
Washington DC 20515Washington DC 20515
8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)
9A. AMENDMENT OF SOLICITATION NO.
ALTIMMUNE, INC. 1305044
9B. DATED (SEE ITEM 11)
910 CLOPPER RD STE 201S GAITHERSBURG MD 208781361
10A. MODIFICATION OF CONTRACT/ORDER NO.
10B. DATED (SEE ITEM 13)
1. CONTRACT ID CODE
The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers
is not extended.
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended , by one of the following methods: (a) By completing Items 8 and 15, and returning copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted ; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR
OFFER. If by virtue of this amendment you desire to change an offer already submitted , such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
|12.||ACCOUNTING AND APPROPRIATION DATA (If required)|
A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
FAR 43.103(a) - By mutual agreement of the parties
D. OTHER (Specify type of modification and authority)
is required to sign this document and return 1
copies to the issuing office.
|14.||DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)|
Tax ID Number:20 ###-###-#### DUNS Number ###-###-####
The purpose of this modification is to:
1)Extend the period of performance end date of contract without additional cost to the
government from 6/30/2021 to 9/30/2021. 2)Revise Article B.2. Estimated Cost AND FIXED FEE
Total Obligated Amount $[***]
Appr. Yr.: 2016 CAN: 1992016 Object Class: 25103
Period of Performance: 07/27/2016 to 09/30/2021
Change Item 1 to read as follows(amount shown is the obligated amount):
Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect.
15A. NAME AND TITLE OF SIGNER (Type or print)
Will Brown, Chief Financial Officer
16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)
KATHLEEN Y. SEARS
/s/ Will Brown
(Signature of person authorized to sign)
15C. DATE SIGNED
Jun 29, 2021
16B. UNITED STATES OF AMERICA
/s/ Kathleen Y. Sears
(Signature of Contracting Officer)
16C. DATE SIGNED
Jun 29, 2021
Previous edition unusable STANDARD FORM 30 (REV. 11/2016)
Prescribed by GSA FAR (48 CFR) 53.243
REFERENCE NO. OF DOCUMENT BEING CONTINUED
CONTINUATION SHEET HHSO100201600008C/P00007
NAME OF OFFEROR OR CONTRACTOR
ALTIMMUNE, INC. 1305044
Altimmune requested a No Cost Extension request for CLIN 0001 -
NSN 7540-01-152-8067OPTIONAL FORM 336 (4-86)
Sponsored by GSA FAR (48 CFR) 53.110
Contract No. HHSO100201600008C
Modification P00007 ALTIMMUNE
Continuation Sheet Block 14
Page 3 of 3
Beginning with the effective date of this modification, the Government and the Contractor mutually agree to the following:
ARTICLE B.2. ESTIMATED COST AND FIXED FEE – paragraph d. is revised as follows:
d. It is estimated that the amount currently allotted will cover performance of the contract through September 30, 2021.
Estimated Period of Performance
Estimated Fixed Fee
Total Estimated Cost
Plus Fixed Fee
July 27, 2016 –
Perform activities to support the conduct of a Phase 1a clinical study and demonstrate safety and immunogenicity in accordance with Article C.1 Statement of Work Study Reports, development
End of Modification P00007
All other terms and conditions of the contract remain in full force and effect.